Janus Henderson Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.48M | Sell |
305,268
-240,558
| -44% | -$4.81M | ﹤0.01% | 883 |
|
|
2025
Q4 | $8.9M | Sell |
545,826
-387,096
| -41% | -$5.85M | ﹤0.01% | 770 |
|
|
2025
Q3 | $10.9M | Buy |
932,922
+883,234
| +1,778% | +$11.5M | 0.01% | 727 |
|
|
2025
Q2 | $575K | Hold |
49,688
| – | – | ﹤0.01% | 1876 |
|
|
2025
Q1 | $455K | Hold |
49,688
| – | – | ﹤0.01% | 2006 |
|
|
2024
Q4 | $714K | Hold |
49,688
| – | – | ﹤0.01% | 1856 |
|
|
2024
Q3 | $1.12M | Hold |
49,688
| – | – | ﹤0.01% | 1605 |
|
|
2024
Q2 | $965K | Buy |
49,688
+10,888
| +28% | +$285K | ﹤0.01% | 1637 |
|
|
2024
Q1 | $1.46M | Hold |
38,800
| – | – | ﹤0.01% | 1438 |
|
|
2023
Q4 | $2.17M | Sell |
38,800
-23
| -0.1% | -$1K | ﹤0.01% | 1213 |
|
|
2023
Q3 | $1.6M | Buy |
38,823
+12
| +0% | +$624 | ﹤0.01% | 1302 |
|
|
2023
Q2 | $2.17M | Sell |
38,811
-49
| -0.1% | -$2.65K | ﹤0.01% | 1201 |
|
|
2023
Q1 | $2.17M | Buy |
38,860
+23,881
| +159% | +$1.12M | ﹤0.01% | 1210 |
|
|
2022
Q4 | $546K | Sell |
14,979
-14,979
| -50% | -$490K | ﹤0.01% | 1661 |
|
|
2022
Q3 | $854K | Buy |
29,958
+13,079
| +77% | +$498K | ﹤0.01% | 1727 |
|
|
2022
Q2 | $764K | Sell |
16,879
-39,232
| -70% | -$2.04M | ﹤0.01% | 1492 |
|
|
2022
Q1 | $4.27M | Sell |
56,111
-201,499
| -78% | -$17.6M | ﹤0.01% | 1045 |
|
|
2021
Q4 | $38.4M | Buy |
257,610
+222,183
| +627% | +$34M | 0.02% | 627 |
|
|
2021
Q3 | $5.16M | Buy |
35,427
+31,529
| +809% | +$5.41M | ﹤0.01% | 1044 |
|
|
2021
Q2 | $764K | Buy |
+3,898
| New | +$705K | ﹤0.01% | 1363 |
|
|
2021
Q1 | – | Sell |
-36,192
| Closed | -$5.13M | – | 1629 |
|
|
2020
Q4 | $5.13M | Buy |
+36,192
| New | +$5.25M | ﹤0.01% | 956 |
|
|
2019
Q4 | – | Sell |
-28,481
| Closed | -$1.44M | – | 1465 |
|
|
2019
Q3 | $1.44M | Buy |
+28,481
| New | +$1.58M | ﹤0.01% | 1189 |
|
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
